
### [MONDO:0017017](http://purl.obolibrary.org/obo/MONDO_0017017)
**Label:** primary interstitial lung disease specific to childhood due to alveolar vascular disorder

**Subclasses:** [MONDO:0007921](http://purl.obolibrary.org/obo/MONDO_0007921) (yellow nail syndrome), [MONDO:0018127](http://purl.obolibrary.org/obo/MONDO_0018127) (16q24.1 microdeletion syndrome), [MONDO:0017018](http://purl.obolibrary.org/obo/MONDO_0017018) (isolated pulmonary capillaritis), [MONDO:0011331](http://purl.obolibrary.org/obo/MONDO_0011331) (congenital chylothorax), [MONDO:0009933](http://purl.obolibrary.org/obo/MONDO_0009933) (congenital pulmonary lymphangiectasia), [MONDO:0009934](http://purl.obolibrary.org/obo/MONDO_0009934) (persistent fetal circulation syndrome), 

**Mapped go classes:** [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0007494](http://purl.obolibrary.org/obo/GO_0007494) (midgut development), [GO:0007498](http://purl.obolibrary.org/obo/GO_0007498) (mesoderm development), [GO:0090131](http://purl.obolibrary.org/obo/GO_0090131) (mesenchyme migration), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:0060841](http://purl.obolibrary.org/obo/GO_0060841) (venous blood vessel development), [GO:0060446](http://purl.obolibrary.org/obo/GO_0060446) (branching involved in open tracheal system development), [GO:0043305](http://purl.obolibrary.org/obo/GO_0043305) (negative regulation of mast cell degranulation), [GO:0048286](http://purl.obolibrary.org/obo/GO_0048286) (lung alveolus development), [GO:0048566](http://purl.obolibrary.org/obo/GO_0048566) (embryonic digestive tract development), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0072189](http://purl.obolibrary.org/obo/GO_0072189) (ureter development), [GO:0010811](http://purl.obolibrary.org/obo/GO_0010811) (positive regulation of cell-substrate adhesion), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0060438](http://purl.obolibrary.org/obo/GO_0060438) (trachea development), [GO:0002053](http://purl.obolibrary.org/obo/GO_0002053) (positive regulation of mesenchymal cell proliferation), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0003214](http://purl.obolibrary.org/obo/GO_0003214) (cardiac left ventricle morphogenesis), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0014822](http://purl.obolibrary.org/obo/GO_0014822) (detection of wounding), [GO:0048371](http://purl.obolibrary.org/obo/GO_0048371) (lateral mesodermal cell differentiation), [GO:0071407](http://purl.obolibrary.org/obo/GO_0071407) (cellular response to organic cyclic compound), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0060463](http://purl.obolibrary.org/obo/GO_0060463) (lung lobe morphogenesis), [GO:0061030](http://purl.obolibrary.org/obo/GO_0061030) (epithelial cell differentiation involved in mammary gland alveolus development), [GO:0060461](http://purl.obolibrary.org/obo/GO_0060461) (right lung morphogenesis), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0051150](http://purl.obolibrary.org/obo/GO_0051150) (regulation of smooth muscle cell differentiation), [GO:0060426](http://purl.obolibrary.org/obo/GO_0060426) (lung vasculature development), [GO:0097070](http://purl.obolibrary.org/obo/GO_0097070) (ductus arteriosus closure), [GO:0048613](http://purl.obolibrary.org/obo/GO_0048613) (embryonic ectodermal digestive tract morphogenesis), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0003197](http://purl.obolibrary.org/obo/GO_0003197) (endocardial cushion development), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0048617](http://purl.obolibrary.org/obo/GO_0048617) (embryonic foregut morphogenesis), [GO:0060425](http://purl.obolibrary.org/obo/GO_0060425) (lung morphogenesis), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001763](http://purl.obolibrary.org/obo/GO_0001763) (morphogenesis of a branching structure), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0051145](http://purl.obolibrary.org/obo/GO_0051145) (smooth muscle cell differentiation), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0072001](http://purl.obolibrary.org/obo/GO_0072001) (renal system development), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0045198](http://purl.obolibrary.org/obo/GO_0045198) (establishment of epithelial cell apical/basal polarity), [GO:0030323](http://purl.obolibrary.org/obo/GO_0030323) (respiratory tube development), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0030198](http://purl.obolibrary.org/obo/GO_0030198) (extracellular matrix organization), [GO:0071345](http://purl.obolibrary.org/obo/GO_0071345) (cellular response to cytokine stimulus), [GO:0098609](http://purl.obolibrary.org/obo/GO_0098609) (cell-cell adhesion), 

**Class expressions from DL-Learner:**

- [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process) 55.62%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 53.74%
- Thing 52.93%
- [GO:0060463](http://purl.obolibrary.org/obo/GO_0060463) (lung lobe morphogenesis) 52.38%
- [GO:0003214](http://purl.obolibrary.org/obo/GO_0003214) (cardiac left ventricle morphogenesis) 52.38%
- [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis) 37.74%
- [GO:0003206](http://purl.obolibrary.org/obo/GO_0003206) (cardiac chamber morphogenesis) 37.74%
- [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.74%
- [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.74%
- [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.74%
- [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.74%
- [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.74%
- [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.74%
- [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.74%
- [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.74%


